Furthermore, the risk of SE is high in patients with androgen-insensitivity syndrome (AIS), a condition associated with aberrant repression of the AR signal due to loss-of-function mutations in the AR gene [13]. The gene discussed is AR; the disease is androgen insensitivity syndrome.